Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Aura Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +2 vs. Q4 2021
- Shares held
- 13.7M
- +621.2K (+4.7%) vs. Q4 2021
- Total value
- $298.8M
- +$78.6M (+35.7%) vs. Q4 2021
- New holders
- 5
- 14 more added
- Sold out
- 3
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 219 | $5.00K | 0.00% | −1,586−87.9% | Reduced |
| Royal Bank of Canada | 345 | $8.00K | 0.00% | −813−70.2% | Reduced |
| Ameritas Investment Partners, Inc. | 421 | $9.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 502 | $11.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 754 | $17.0K | 0.00% | −1,893−71.5% | Reduced |
| Amalgamated Bank | 791 | $17.0K | 0.00% | +791 | New |
| Amalgamated Financial Corp. | 791 | $17.0K | 0.00% | +791 | New |
| Tower Research Capital LLC (TRC) | 1,109 | $24.0K | 0.00% | +451+68.5% | Added |
| Morgan Stanley | 1,109 | $24.0K | 0.00% | +575+107.7% | Added |
| Wells Fargo & Company | 1,221 | $27.0K | 0.00% | −2,047−62.6% | Reduced |
| STRS Ohio | 1,300 | $28.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 2,358 | $52.0K | 0.00% | −657−21.8% | Reduced |
| JPMorgan Chase & Co | 2,628 | $58.0K | 0.00% | −3,967−60.2% | Reduced |
| American International Group, Inc. | 2,782 | $61.0K | 0.00% | −115−4.0% | Reduced |
| Deutsche Bank AG | 2,950 | $65.0K | 0.00% | −360−10.9% | Reduced |
| New York State Common Retirement Fund | 6,252 | $138.0K | 0.00% | +3,584+134.3% | Added |
| Bank of America Corp | 11,857 | $261.0K | 0.00% | +4,131+53.5% | Added |
| Bank of New York Mellon Corp | 14,496 | $319.0K | 0.00% | +14,496 | New |
| Charles Schwab Investment Management Inc | 15,379 | $339.0K | 0.00% | +3,557+30.1% | Added |
| Northern Trust Corp | 46,071 | $1.01M | 0.00% | +196+0.4% | Added |
| Allianz Asset Management GmbH | 55,145 | $1.21M | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 59,697 | $1.31M | 0.00% | +59,697 | New |
| State Street Corp | 84,982 | $1.87M | 0.00% | +37,797+80.1% | Added |
| Geode Capital Management, LLC | 105,334 | $2.32M | 0.00% | +3,259+3.2% | Added |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $4.62M | 1.42% | +210,000 | New |
| Vanguard Group Inc | 228,633 | $5.03M | 0.00% | +2,375+1.0% | Added |
| BlackRock Inc. | 275,027 | $6.05M | 0.00% | +36,244+15.2% | Added |
| Nantahala Capital Management, LLC | 301,990 | $6.64M | 0.46% | +202,844+204.6% | Added |
| FMR LLC | 494,109 | $10.9M | 0.00% | +22,809+4.8% | Added |
| Rock Springs Capital Management LP | 1,008,114 | $22.2M | 0.56% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,297,019 | $28.5M | 0.05% | +41,539+3.3% | Added |
| Citadel Advisors LLC | 2,316,653 | $48.3M | 0.06% | +1,551+0.1% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $66.9M | 18.12% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 4,112,870 | $90.5M | 1.09% | 00.0% | Unchanged |
| Caas Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −3,886−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −150−100.0% | Sold out |